Regulation of microglial inflammatory response by sodium butyrate and short‐chain fatty acids

No abstract is available for this paper.

• Publication year

  2004

• Venue

  British Journal of Pharmacology

• Publication date

  2004-03-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1038/sj.bjp.0705682PMID 14744800PMCID PMC1574260
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition

  2003cited by this paper
• Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics?

  2003influential reference
• Search for a common mechanism of mood stabilizers.

  2003cited by this paper
• Regulation of microglial inflammatory response by histone deacetylase inhibitors

  2003cited by this paper
• Inhibition of histone deacetylase activity by butyrate.

  2003cited by this paper
• Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

  2002cited by this paper
• Inflammatory response in acute traumatic brain injury: a double-edged sword

  2002cited by this paper
• Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression

  2002cited by this paper
• Inflammation in neurodegenerative disease--a double-edged sword.

  2002cited by this paper
• The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.

  2002cited by this paper
• Regulating factors for microglial activation.

  2002cited by this paper
• Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity.

  2001cited by this paper
• Characterization of aging-associated up-regulation of constitutive nuclear factor-kappa B binding activity.

  2001cited by this paper
• Beta-amyloid (1-42) affects MTT reduction in astrocytes: implications for vesicular trafficking and cell functionality.

  2001cited by this paper
• Butyrate Suppression of Colonocyte NF-κB Activation and Cellular Proteasome Activity*

  2001influential reference
• Cytokine-activated degradation of inhibitory κB protein α is inhibited by the short-chain fatty acid butyrate

  2001cited by this paper
• Cytokine-activated degradation of inhibitory kappaB protein alpha is inhibited by the short-chain fatty acid butyrate.

  2001cited by this paper
• Reversal of methylation-mediated repression with short-chain fatty acids: evidence for an additional mechanism to histone deacetylation.

  2001cited by this paper
• Characterization of Aging-Associated Up-Regulation of Constitutive Nuclear Factor-κB Binding Activity

  2001cited by this paper
• [Regulating factors for microglial activation].

  2000cited by this paper
• Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer.

  2000cited by this paper
• Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease.

  2000cited by this paper
• Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease

  2000cited by this paper
• The inhibitory action of butyrate on lipopolysaccharide-induced nitric oxide production in RAW 264.7 murine macrophage cells

  2000cited by this paper
• Rationale for the luminal provision of butyrate in intestinal diseases

  2000influential reference
• Human Brain Short Chain l-3-Hydroxyacyl Coenzyme A Dehydrogenase Is a Single-domain Multifunctional Enzyme

  1999cited by this paper
• NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.

  1998cited by this paper
• Mouse microglial cells express a plasma membrane pore gated by extracellular ATP.

  1996cited by this paper
• Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-kappa B.

  1996cited by this paper
• The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases.

  1995cited by this paper
• A simple method for organotypic cultures of nervous tissue.

  1991cited by this paper
• A simple method for organotypic cultures of nervous tissue

  1991cited by this paper
• Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

  1983cited by this paper

• The Emerging Role of the Brain–Gut Axis in Amyotrophic Lateral Sclerosis: Pathogenesis, Mechanisms, and Therapeutic Perspectives

  2025cites this paper
• Pediatric acute-onset neuropsychiatric syndromes and the gut-oral-brain axis: a narrative review of emerging microbiome-immune interactions and therapeutic perspectives

  2025cites this paper
• Neuroprotective effects of Walnut kernel polysaccharides against ochratoxin A-induced hippocampal neurotoxicity by modulating the gut-brain axis

  2025cites this paper
• Association between plasma short-chain fatty acids and inflammation in human immunodeficiency virus-associated neurocognitive disorder: a pilot study

  2025cites this paper
• Role of microbiota in pain: From bench to bedside

  2025cites this paper
• IUPHAR Review: Microbiota-Gut-Brain Axis and its role in Neuropsychiatric Disorders.

  2025cites this paper
• The Role of the Gut Microbiota in Modulating Signaling Pathways and Oxidative Stress in Glioma Therapies

  2025cites this paper
• Therapeutic Horizons: Gut Microbiome, Neuroinflammation, and Epigenetics in Neuropsychiatric Disorders

  2025cites this paper
• Dose-dependent dual effects of HDAC inhibitors on glial inflammatory response

  2025cites this paper
• The Metabolomic Mind: Microbial Metabolite Programming of Microglia

  2025cites this paper
• The metabolic dialogue between intratumoural microbes and cancer: implications for immunotherapy

  2025cites this paper
• The Microbiota–Gut–Brain Axis in Autism: Associations, Causal Inference, and Interventions—A Narrative Review

  2025cites this paper
• Butyrate modifies epigenetic and immune pathways in peripheral mononuclear cells from children with neurodevelopmental disorders associated with chromatin dysregulation.

  2025cites this paper
• Polygonati Rhizoma polysaccharide suppresses microglial activation and promotes functional recovery of spinal cord via improving intestinal microbiota.

  2025cites this paper
• Impact of gut microbiome on atrial fibrillation: Mechanistic insights and future directions in individualized medicine

  2025cites this paper
• Exploration of the Possible Relationships Between Gut and Hypothalamic Inflammation and Allopregnanolone: Preclinical Findings in a Post-Finasteride Rat Model

  2025cites this paper
• Burden of negative energy balance in anorexia nervosa: Role of circadian rhythm, mitochondrial dynamics, microbiota-gut-brain axis and their interactions.

  2025cites this paper
• Cadmium-induced gut dysbiosis precedes the onset of hippocampus-dependent learning and memory deficits in mice

  2025cites this paper
• Role of dietary fiber and short-chain fatty acids in preventing neurodegenerative diseases through the gut-brain axis

  2025cites this paper
• The impact of nutritional and exercise interventions on Alzheimer’s disease pathophysiology via modulation of the microbiota-gut-brain-axis

  2025cites this paper
• Diet alters the effects of lipopolysaccharide on intestinal health and cecal microbiota composition in C57Bl/6 male mice.

  2025cites this paper
• MICROBIAL METABOLITES REGULATE SOCIAL NOVELTY VIA CAMKII NEURONS IN THE BNST

  2025cites this paper
• Microbiome-Glia Crosstalk: Bridging the Communication Divide in the Central Nervous System

  2024cites this paper
• Bioinformatics Approach to Identify the Pathogenetic Link of Gut Microbiota-Derived Short-Chain Fatty Acids and Ischemic Stroke

  2024cites this paper
• Propionate Decreases Microglial Activation but Impairs Phagocytic Capacity in Response to Aggregated Fibrillar Amyloid Beta Protein.

  2024cites this paper
• DUALISTIC SAHA DOSE-DEPENDENT EFFECTS ON GLIAL-INFLAMMATORY RESPONSE

  2024cites this paper
• The role of short-chain fatty acids in central nervous system diseases: A bibliometric and visualized analysis with future directions

  2024cites this paper
• The effects of inulin supplementation on clinical indices, oxidative stress and inflammatory biomarkers in women with migraine: A double-blind, placebo-controlled, randomized trial

  2024cites this paper
• Association of Gut Dysbiosis with Potential Mechanisms Leading to Atrial Fibrillation: A Narrative Review

  2024cites this paper
• Sodium butyrate activates the KATP channels to regulate the mechanism of Parkinson's disease microglia model inflammation

  2024cites this paper
• Young rat microbiota extracts strongly inhibit fibrillation of α-synuclein and protect neuroblastoma cells and zebrafish against α-synuclein toxicity

  2024cites this paper
• Protection of beta cells against cytokine‐induced apoptosis by the gut microbial metabolite butyrate

  2024cites this paper
• Frataxin deficiency shifts metabolism to promote reactive microglia via glucose catabolism

  2024cites this paper
• The microbiota-gut-brain axis: a potential target in the small-molecule compounds and gene therapeutic strategies for Parkinson’s disease

  2024cites this paper
• Post-translational modifications in sepsis-induced organ dysfunction: mechanisms and implications

  2024cites this paper
• Impact of micronutrients and nutraceuticals on cognitive function and performance in Alzheimer's disease.

  2024cites this paper
• Increased levels of Escherichia-Shigella and Klebsiella in the gut contribute to the responsivity of placebo analgesia.

  2024cites this paper
• Altered gut microbiota and systemic immunity in Chinese patients with schizophrenia comorbid with metabolic syndrome

  2024cites this paper
• The Human Microbiome-A Physiologic Perspective.

  2024cites this paper
• Gut microbial metabolism in Alzheimer's disease and related dementias

  2024cites this paper
• Double-side role of short chain fatty acids on host health via the gut-organ axes

  2024cites this paper
• Activation of aryl hydrocarbon receptor (AhR) in Alzheimer’s disease: role of tryptophan metabolites generated by gut host-microbiota

  2023cites this paper
• Mechanisms of Blood–Brain Barrier Protection by Microbiota-Derived Short-Chain Fatty Acids

  2023cites this paper
• Butyrate suppresses atherosclerotic inflammation by regulating macrophages and polarization via GPR43/HDAC-miRNAs axis in ApoE−/− mice

  2023cites this paper
• Can bugs be an alternative or adjuvant to drugs in schizophrenia?

  2023cites this paper
• Biomimetic Nanocarriers Harnessing Microbial Metabolites Usher the Path for Brain Disease Therapy

  2023cites this paper
• Elucidating gut microbiota–hippocampus interactions in emerging psychosis: A new perspective for the development of early interventions for memory impairments

  2023cites this paper
• Gut Microbiota and Atrial Fibrillation: Pathogenesis, Mechanisms and Therapies

  2023cites this paper
• Role of Bmal1 and Gut Microbiota in Alzheimer's Disease and Parkinson's Disease Pathophysiology: The Probable Effect of Melatonin on Their Association.

  2023cites this paper
• Molecular Landscape of Tourette’s Disorder

  2023cites this paper
• Prebiotic fructooligosaccharides ameliorate the lipop olysaccharides-induced oxidative stress of mice brain

  2023cites this paper
• Inulin Attenuates Blood-Brain Barrier Permeability and Alleviates Behavioral Disorders by Modulating the TLR4/MyD88/NF-κB Pathway in Mice with Chronic Stress.

  2023cites this paper
• Impact of breastfeeding and other early-life factors on the development of the oral microbiome

  2023cites this paper
• Dysbiosis of the Beneficial Gut Bacteria in Patients with Parkinson's Disease from India

  2023cites this paper
• Memory Reflections of the Microbiota-Gut and Oligodendrocyte Axis.

  2023cites this paper
• Butyrate Protects against γ-d-Glutamyl-meso-diaminopimelic Acid-Induced Inflammatory Response and Tight Junction Disruption through Histone Deacetylase 3 Inhibition in Bovine Mammary Epithelial Cells.

  2023cites this paper
• Microbial metabolites regulate social novelty via CaMKII neurons in the BNST.

  2023cites this paper
• Gut microbiota regulates blood‐cerebrospinal fluid barrier function and Aβ pathology

  2023cites this paper
• Short-chain fatty and carboxylic acid changes associated with fecal microbiota transplant communally influence microglial inflammation

  2023cites this paper
• Traditional Chinese medicine for the treatment of Alzheimer's disease: A focus on the microbiota-gut-brain axis.

  2023cites this paper
• The gut microbiota-neuroimmune crosstalk and neuropathic pain: a scoping review

  2023cites this paper
• Histone deacetylase 3 regulates microglial function through histone deacetylation

  2023cites this paper
• Maturation, Morphology, and Function: The Decisive Role of Intestinal Flora on Microglia: A Review.

  2023cites this paper
• Short-chain fatty acids ameliorate spinal cord injury recovery by regulating the balance of regulatory T cells and effector IL-17+ γδ T cells

  2023cites this paper
• Major Depressive Disorder and Gut Microbiota: Role of Physical Exercise

  2023cites this paper
• Effects of a high-prebiotic diet versus probiotic supplements versus synbiotics on adult mental health: The “Gut Feelings” randomised controlled trial

  2023cites this paper
• Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections

  2023cites this paper
• Gut-to-brain spreading of pathology in synucleinopathies: A focus on molecular signalling mediators.

  2023cites this paper
• The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials.

  2023cites this paper
• Microbiota‐microglia connections in age‐related cognition decline

  2022cites this paper
• Butyrate inhibits IL-1β-induced inflammatory gene expression by suppression of NF-κB activity in pancreatic beta cells

  2022cites this paper
• Current understanding of the human microbiome in glioma

  2022cites this paper
• Central and peripheral regulations mediated by short-chain fatty acids on energy homeostasis.

  2022cites this paper
• Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia

  2022cites this paper
• The Relationship Between Atrial Fibrillation and Intestinal Flora With Its Metabolites

  2022cites this paper
• Gut Microbiota Mediates the Susceptibility of Mice to Sepsis-Associated Encephalopathy by Butyric Acid

  2022cites this paper
• Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease

  2022cites this paper
• The Endocannabinoids-Microbiota Partnership in Gut-Brain Axis Homeostasis: Implications for Autism Spectrum Disorders

  2022cites this paper
• The impact of maternal high-fat diet on offspring neurodevelopment

  2022cites this paper
• Pediococcus pentosaceus LAB6- and Lactiplantibacillus plantarum LAB12-Derived Cell Free Supernatant Inhibited RhoA Activation and Reduced Amyloid-Β In Vitro.

  2022cites this paper
• Gut brain interaction theory reveals gut microbiota mediated neurogenesis and traditional Chinese medicine research strategies

  2022cites this paper
• Stress induced microglial activation contributes to depression.

  2022cites this paper
• ALSUntangled #64: butyrates

  2022cites this paper
• Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease

  2022cites this paper
• Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch’s postulates

  2022cites this paper
• Immunoregulatory Effect of Short-Chain Fatty Acids from Gut Microbiota on Obstructive Sleep Apnea-Associated Hypertension

  2022cites this paper
• Connecting gut microbiomes and short chain fatty acids with the serotonergic system and behavior in Gallus gallus and other avian species

  2022cites this paper
• Gut microbiota in hypertensive patients with versus without obstructive sleep apnea

  2022cites this paper
• The role of short-chain fatty acids in central nervous system diseases

  2022cites this paper
• Crosstalk between the aging intestinal microflora and the brain in ischemic stroke

  2022cites this paper
• Microbiome influences on neuro-immune interactions in neurodegenerative disease.

  2022cites this paper
• Metformin: Expanding the Scope of Application—Starting Earlier than Yesterday, Canceling Later

  2022cites this paper
• The gut microbiome and adult hippocampal neurogenesis: A new focal point for epilepsy?

  2022cites this paper
• Xiaoyao San ameliorates high-fat diet-induced anxiety and depression via regulating gut microbiota in mice.

  2022cites this paper
• Intestinal Microbiota and Sclerosis Lateral Amyotrophic

  2022cites this paper
• Inulin Supplementation Mitigates Gut Dysbiosis and Brain Impairment Induced by Mild Traumatic Brain Injury during Chronic Phase

  2022cites this paper
• Short chain fatty acids: Microbial metabolites for gut-brain axis signalling.

  2022cites this paper
• Shedding light on biological sex differences and microbiota–gut–brain axis: a comprehensive review of its roles in neuropsychiatric disorders

  2022cites this paper
• Dietary Fiber Modulates the Release of Gut Bacterial Products Preventing Cognitive Decline in an Alzheimer’s Mouse Model

  2022cites this paper
• Can dietary patterns prevent cognitive impairment and reduce Alzheimer's disease risk: exploring the underlying mechanisms of effects.

  2022cites this paper